Financial Metrics Exploration: Understanding Beam Therapeutics Inc (BEAM) Through Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Beam Therapeutics Inc (NASDAQ: BEAM) was $23.93 for the day, down -1.77% from the previous closing price of $24.36. In other words, the price has decreased by -$1.77 from its previous closing price. On the day, 2.3 million shares were traded. BEAM stock price reached its highest trading level at $24.79 during the session, while it also had its lowest trading level at $21.46.

Ratios:

Our analysis of BEAM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.

On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.

JP Morgan Upgraded its Neutral to Overweight on January 29, 2024, whereas the target price for the stock was revised from $38 to $40.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 14 ’24 when Ciaramella Giuseppe sold 51,110 shares for $26.27 per share. The transaction valued at 1,342,752 led to the insider holds 160,260 shares of the business.

Giuseppe Ciaramella bought 102,220 shares of BEAM for $2,519,723 on Oct 14 ’24. On Oct 07 ’24, another insider, Burrell Terry-Ann, who serves as the Officer of the company, bought 185,565 shares for $23.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2007645696 and an Enterprise Value of 1082907264. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.64 while its Price-to-Book (P/B) ratio in mrq is 2.31. Its current Enterprise Value per Revenue stands at 3.071 whereas that against EBITDA is -6.648.

Stock Price History:

Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $18.85. The 50-Day Moving Average of the stock is -1.20%, while the 200-Day Moving Average is calculated to be -10.55%.

Shares Statistics:

BEAM traded an average of 838.65K shares per day over the past three months and 1058500 shares per day over the past ten days. A total of 81.63M shares are outstanding, with a floating share count of 71.66M. Insiders hold about 13.05% of the company’s shares, while institutions hold 80.16% stake in the company. Shares short for BEAM as of 1728950400 were 11160201 with a Short Ratio of 13.31, compared to 1726185600 on 10963771. Therefore, it implies a Short% of Shares Outstanding of 11160201 and a Short% of Float of 17.740000000000002.

Most Popular